Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
View ORCID ProfilePhilip A. Mudd, View ORCID ProfileJeremy Chase Crawford, View ORCID ProfileJackson S. Turner, View ORCID ProfileAisha Souquette, Daniel Reynolds, View ORCID ProfileDiane Bender, James P. Bosanquet, Nitin J. Anand, David A. Striker, R. Scott Martin, View ORCID ProfileAdrianus C. M. Boon, View ORCID ProfileStacey L. House, View ORCID ProfileKenneth E. Remy, Richard S. Hotchkiss, Rachel M. Presti, Jane A. O’Halloran, View ORCID ProfileWilliam G. Powderly, View ORCID ProfilePaul G. Thomas, View ORCID ProfileAli H. Ellebedy
doi: https://doi.org/10.1101/2020.05.28.20115667
Philip A. Mudd
1Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO, USA
Jeremy Chase Crawford
2Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA
Jackson S. Turner
3Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
Aisha Souquette
2Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA
Daniel Reynolds
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
Diane Bender
5Bursky Center for Human Immunology and Immunotherapy Program, Washington University School of Medicine, Saint Louis, MO, USA
James P. Bosanquet
6Department of Critical Care, Missouri Baptist Medical Center, Saint Louis, MO, USA
Nitin J. Anand
6Department of Critical Care, Missouri Baptist Medical Center, Saint Louis, MO, USA
David A. Striker
6Department of Critical Care, Missouri Baptist Medical Center, Saint Louis, MO, USA
R. Scott Martin
6Department of Critical Care, Missouri Baptist Medical Center, Saint Louis, MO, USA
Adrianus C. M. Boon
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
Stacey L. House
1Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO, USA
Kenneth E. Remy
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
7Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO, USA
8Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA
Richard S. Hotchkiss
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
8Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA
9Department of Surgery, Washington University School of Medicine, Saint Louis, MO, USA
Rachel M. Presti
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
Jane A. O’Halloran
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
William G. Powderly
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
Paul G. Thomas
2Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA
Ali H. Ellebedy
3Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
4Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA
5Bursky Center for Human Immunology and Immunotherapy Program, Washington University School of Medicine, Saint Louis, MO, USA
Data Availability
Raw flow cytometry and cytokine data can be found in Supplementary Tables 1 and 2, respectively. Single cell gene expression sequences have been uploaded to the NCBI Short Read Archive under BioProject ID PRJNA630932.
Posted May 30, 2020.
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, James P. Bosanquet, Nitin J. Anand, David A. Striker, R. Scott Martin, Adrianus C. M. Boon, Stacey L. House, Kenneth E. Remy, Richard S. Hotchkiss, Rachel M. Presti, Jane A. O’Halloran, William G. Powderly, Paul G. Thomas, Ali H. Ellebedy
medRxiv 2020.05.28.20115667; doi: https://doi.org/10.1101/2020.05.28.20115667
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, James P. Bosanquet, Nitin J. Anand, David A. Striker, R. Scott Martin, Adrianus C. M. Boon, Stacey L. House, Kenneth E. Remy, Richard S. Hotchkiss, Rachel M. Presti, Jane A. O’Halloran, William G. Powderly, Paul G. Thomas, Ali H. Ellebedy
medRxiv 2020.05.28.20115667; doi: https://doi.org/10.1101/2020.05.28.20115667
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2833)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12534)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2840)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)